LEO 29102   Click here for help

GtoPdb Ligand ID: 12724

Synonyms: compound 20 [PMID: 24984230] | LEO-29102 | LEO29102
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: LEO 29102 is a phosphodiesterase 4 (PDE4) inhibitor, that was designed as a topical anti-inflammatory agent [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 11
Topological polar surface area 86.22
Molecular weight 441.31
XLogP 1.59
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCCNC(=O)COC1=C(C(=CC=C1C(=O)CC2=C(C=NC=C2Cl)Cl)OC)OC
Isomeric SMILES O=C(C1=C(OCC(NCCC)=O)C(OC)=C(C=C1)OC)CC2=C(Cl)C=NC=C2Cl
InChI InChI=1S/C20H22Cl2N2O5/c1-4-7-24-18(26)11-29-19-12(5-6-17(27-2)20(19)28-3)16(25)8-13-14(21)9-23-10-15(13)22/h5-6,9-10H,4,7-8,11H2,1-3H3,(H,24,26)
InChI Key HOKIHKLKOZWCRY-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
LEO 29102 was advanced to clinical evaluation asa topical agent for the treatment of inflammatory skin conditions.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT01037881 LEO 29102 Cream in the Treatment of Atopic Dermatitis Phase 2 Interventional LEO Pharma
NCT01466478 An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis Vulgaris Phase 1 Interventional LEO Pharma